article thumbnail

Digital therapeutics startup Neuroglee raises $10M to help people with neurodegenerative conditions

TechCrunch

Neuroglee Therapeutics , a startup developing digital therapeutics for people with neurodegenerative diseases, has raised a $10 million Series A led by Openspace Ventures and EDBI. million to develop digital therapeutics for neurodegenerative diseases. Neuroglee gets $2.3

article thumbnail

The growing power of digital healthcare: 6 trends to watch in 2022

TechCrunch

Digital therapeutics will rewrite the future of healthcare. Digital therapeutics is perhaps the most innovative development in healthcare today and has the potential to dramatically change how care is delivered.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

6 questions investors should ask when evaluating psychedelic biotech companies

TechCrunch

As a venture firm that invests in psychedelics, we receive hundreds of pitches every month from founders developing psychedelic therapeutics. Our fund has invested more than $15 million in companies developing psychedelic therapeutics. Greg Kubin is a partner at PsyMed Ventures and co-host of Business Trip.

article thumbnail

metaMe Health Raises $2.2M in Funding

HPA

We’re excited to share that metaMe Health , a prescription digital therapeutics (PDT) company, today announced raising $2.2M metaMe Health is the developer of Regulora®, the first FDA-authorized PDT specifically for abdominal pain associated with Irritable Bowel Syndrome (IBS) in adults. in funding.

health 113
article thumbnail

BrainCheck brings in another $10M to detect, manage cognitive impairment

TechCrunch

BrainCheck , a Houston- and Austin-based company developing cognitive healthcare software to aid physicians in detecting and managing this type of care, raised $10 million in Series B funding to expand its R&D and go-to-market capabilities as it works on new digital therapeutics for Alzheimer’s and related dementias.

article thumbnail

metaMe Health Raises $2.2M in Funding

HPA

We’re excited to share that metaMe Health , a prescription digital therapeutics (PDT) company, today announced raising $2.2M metaMe Health is the developer of Regulora®, the first FDA-authorized PDT specifically for abdominal pain associated with Irritable Bowel Syndrome (IBS) in adults. in funding.

health 91
article thumbnail

[Eko Health in PR Newswire] Astellas and Eko Health announce agreement to incorporate next generation Eko CORE 500™ Digital Stethoscope into Z1608, an innovative solution under development for heart failure patients built on Welldoc’s proven digital therapeutic platform

OurCrowd

The post [Eko Health in PR Newswire] Astellas and Eko Health announce agreement to incorporate next generation Eko CORE 500™ Digital Stethoscope into Z1608, an innovative solution under development for heart failure patients built on Welldoc’s proven digital therapeutic platform appeared first on OurCrowd Blog.